Darton T - Search Results

1

Are we good at thromboembolic disease prophylaxis - an audit of the use of risk assessment forms in emergency medical admissions.

Sooriakumaran P, Burton L, Choudhary R, Darton T, Woods C, Lloyd-Mostyn RH, Fernando DJ, Thomson GA. Sooriakumaran P, et al. Among authors: darton t. Int J Clin Pract. 2005 May;59(5):605-11. doi: 10.1111/j.1742-1241.2005.00525.x. Int J Clin Pract. 2005. PMID: 15857359

2

Seasonal Azithromycin Use in Paediatric Protracted Bacterial Bronchitis Does Not Promote Antimicrobial Resistance but Does Modulate the Nasopharyngeal Microbiome.

Hardman SJ, Shackley FM, Ugonna K, Darton TC, Rigby AS, Bogaert D, Binkowska JM, Condliffe AM. Hardman SJ, et al. Among authors: darton tc. Int J Mol Sci. 2023 Nov 7;24(22):16053. doi: 10.3390/ijms242216053. Int J Mol Sci. 2023. PMID: 38003242 Free PMC article.

3

Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial.

Lee IT, Cosgrove CA, Moore P, Bethune C, Nally R, Bula M, Kalra PA, Clark R, Dargan PI, Boffito M, Sheridan R, Moran E, Darton TC, Burns F, Saralaya D, Duncan CJA, Lillie PJ, San Francisco Ramos A, Galiza EP, Heath PT, Girard B, Parker C, Rust D, Mehta S, de Windt E, Sutherland A, Tomassini JE, Dutko FJ, Chalkias S, Deng W, Chen X, Feng J, Tracy L, Zhou H, Miller JM, Das R; Study Investigators. Lee IT, et al. Among authors: darton tc. Lancet Infect Dis. 2023 Sep;23(9):1007-1019. doi: 10.1016/S1473-3099(23)00295-5. Epub 2023 Jun 19. Lancet Infect Dis. 2023. PMID: 37348519 Free article. Clinical Trial.

4

Missed opportunities to diagnose Plasmodium falciparum malaria: results of a regional service evaluation.

Green ST, Jary HR, Darton TC, Darton TC. Green ST, et al. Among authors: darton tc. J Infect. 2009 Feb;58(2):172-3. doi: 10.1016/j.jinf.2008.12.001. Epub 2009 Jan 1. J Infect. 2009. PMID: 19121545 No abstract available.

5

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Diabetes Endocrinol. 2023 Dec;11(12):905-914. doi: 10.1016/S2213-8587(23)00253-X. Epub 2023 Oct 18. Lancet Diabetes Endocrinol. 2023. PMID: 37865101 Free PMC article. Clinical Trial.

6

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk; RECOVERY Collaborative Group. RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk, et al. Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13. Lancet. 2023. PMID: 37060915 Free PMC article. Clinical Trial.

7

Managing and monitoring tuberculosis using web-based tools in combination with traditional approaches.

Chapman AL, Darton TC, Foster RA. Chapman AL, et al. Clin Epidemiol. 2013 Nov 21;5:465-73. doi: 10.2147/CLEP.S37072. eCollection 2013. Clin Epidemiol. 2013. PMID: 24294008 Free PMC article. Review.

8

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet Child Adolesc Health. 2024 Mar;8(3):190-200. doi: 10.1016/S2352-4642(23)00316-4. Epub 2024 Jan 22. Lancet Child Adolesc Health. 2024. PMID: 38272046 Free article. Clinical Trial.

9

Baseline factors predicting the duration of intravenous antibiotic therapy for cellulitis in an outpatient setting.

Lillie PJ, Andrews D, Eaves K, Darton TC, Chapman AL. Lillie PJ, et al. Among authors: darton tc. Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):347-9. doi: 10.1007/s10096-009-0855-9. Eur J Clin Microbiol Infect Dis. 2010. PMID: 20063026 No abstract available.

10

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2021 Feb 13;397(10274):605-612. doi: 10.1016/S0140-6736(21)00149-5. Epub 2021 Feb 2. Lancet. 2021. PMID: 33545096 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page